Activation of Mammalian Target of Rapamycin Signaling Promotes Cell Cycle Progression and Protects Cells from Apoptosis in Mantle Cell Lymphoma

Evangelia Peponi(The University of Texas MD Anderson Cancer Center), L. Jeffrey Medeiros(The University of Texas MD Anderson Cancer Center)

American Journal Of Pathology

December 1, 2006

10.2353/ajpath.2006.051078

Cited by 118

Related Papers

Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)

|Leukemia|2011|66

Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis

|Modern Pathology|2004|24